What investigations should be performed in a 7-year-old boy with ecchymotic patches and a family history of similar bruising in his grandparents?

Investigations for a 7-Year-Old with Ecchymotic Patches and Family History

This child requires a systematic two-stage laboratory evaluation to differentiate between inherited platelet function disorders (IPFD), von Willebrand disease (VWD), and other bleeding disorders, given the positive family history and ecchymotic patches.

Initial Clinical Assessment

Before ordering tests, document the following specific details:

• Bleeding history: Unexplained or extensive bruising patterns, epistaxis, bleeding after dental extractions or invasive procedures 1
• Medication/dietary history: Any drugs or foods interfering with platelet function 1
• Physical examination findings:
  • Location of ecchymoses (leg bruises suggest hematologic disorders more than TEN location [torso, ears, neck]) 2
  • Syndromic features: hearing loss, heart/facial/bone dysmorphisms, ocular involvement, skin discoloration 1
  • Signs of liver disease, splenomegaly, joint laxity, telangiectasia 3
• Family history specificity: Which grandparents, severity of their symptoms, any diagnosed bleeding disorders 3

Use a bleeding assessment tool (BAT) to quantify symptom severity and justify further testing 1.

First-Stage Laboratory Investigations

Order these tests initially 1, 3:

1. Complete blood count (CBC) - assess for thrombocytopenia (mild thrombocytopenia does not exclude IPFD) 1
2. Blood smear - evaluate platelet morphology 1
3. Prothrombin time (PT) 3
4. Activated partial thromboplastin time (aPTT) 3
5. VWF antigen (VWF:Ag) 3
6. VWF ristocetin cofactor activity (VWF:RCo) 3
7. Factor VIII coagulant activity (FVIII) 3

These seven tests constitute the essential first-stage workup and should all be ordered together at the initial evaluation 1, 3.

Second-Stage Investigations (If First-Stage Abnormal)

Proceed to these specialized tests if initial results are abnormal 1, 3:

• Light transmission aggregometry (LTA) with limited agonists - screens for platelet function defects 1
• Platelet granule release assessment 1
• VWF multimer analysis - if VWF:RCo is low or VWF:RCo/VWF:Ag ratio is <0.5-0.7 3
• Flow cytometry - for specific platelet receptor defects if LTA is abnormal 1

Critical Interpretation Points

If all first-stage and second-stage investigations are normal, and personal/family histories show no specific bleeding disorder patterns, it is highly unlikely a bleeding disorder will be missed 4. However, recognize these limitations:

• Some platelet function tests are insensitive and poorly standardized 1
• Normal coagulation tests do not absolutely exclude all bleeding disorders 4, 5
• Artifact is common in pediatric samples 5

Important Clinical Caveat

In this case with family history in grandparents specifically, von Willebrand disease (Type 1 or 2) is the most likely inherited bleeding disorder 3, 2. The VWF testing panel (VWF:Ag, VWF:RCo, FVIII) is therefore particularly critical. If the VWF:RCo/VWF:Ag ratio is abnormally low, this suggests Type 2 VWD and mandates multimer analysis 3.

Pitfalls to Avoid

• Do not skip the initial VWF panel even if PT/aPTT are normal - VWD may not prolong these tests 3
• Do not assume normal first-stage tests completely exclude bleeding disorders - some IPFD require specialized platelet function testing 1
• Ensure proper sample collection technique to minimize artifact, especially in children 5
• Consider that leg bruising patterns favor hematologic disorders over non-accidental trauma 2